79 related articles for article (PubMed ID: 38535990)
1. Identification of protein methyltransferases 5 associated with ferroptosis and immune cell infiltration of head and neck squamous cell carcinoma.
Zhang X; Liu Q; Wang L; Peng Q
Aging (Albany NY); 2024 Apr; 16(8):7426-7436. PubMed ID: 38663941
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis revealed P4Hs as new biomarkers for prognosis and immunotherapy in head and neck cancer.
Zhou H; Lei Y; Luo J; Wang J; Peng L; Mou K; Xiang L; Luo Y
Sci Rep; 2024 May; 14(1):12234. PubMed ID: 38806556
[TBL] [Abstract][Full Text] [Related]
3. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
Liu D; Zhong M; Zhan D; Zhang Y; Liu S
Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
[TBL] [Abstract][Full Text] [Related]
4. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
Dlamini Z; Alaouna M; Mbatha S; Bhayat A; Mabongo M; Chatziioannou A; Hull R
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804181
[TBL] [Abstract][Full Text] [Related]
5. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma.
Lu D; Mihoayi M; Ablikim Y; Arikin A
Aging (Albany NY); 2024 Mar; 16(7):5929-5948. PubMed ID: 38535990
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
7. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
Front Immunol; 2022; 13():975847. PubMed ID: 36091055
[TBL] [Abstract][Full Text] [Related]
8. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
9. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis inhibition enhances induced pluripotent stem cell generation during T cell reprogramming.
Ren J; Zhang X; Zhang Z; Pan J; Hao Z; Li J; Liu J
Biochem Biophys Res Commun; 2023 May; 656():30-37. PubMed ID: 36947964
[TBL] [Abstract][Full Text] [Related]
12. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
13. Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment.
Jin R; Hao J; Yu J; Wang P; Sauter ER; Li B
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765614
[TBL] [Abstract][Full Text] [Related]
14. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.
Ruffin AT; Li H; Vujanovic L; Zandberg DP; Ferris RL; Bruno TC
Nat Rev Cancer; 2023 Mar; 23(3):173-188. PubMed ID: 36456755
[TBL] [Abstract][Full Text] [Related]
15. Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells.
Gedaly R; Cornea V; Turcios L; Edmisson JS; Harris DD; Watt DS; Chapelin F; Khurana A; Mei X; Liu C; Taylor I; Gonzalez-Valdivieso J; Mitchel H; Ruffing A; Chishti A; Orozco G; Zwischenberger J; Evers BM; Marti F
Sci Rep; 2022 Nov; 12(1):19112. PubMed ID: 36352020
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
